Pervasis Therapeutics, Inc.

Pervasis Therapeutics, Inc. (Pervasis) is a clinical-stage cell-based biotechnology company, engaged in provision of biologically active cellular therapies for treating vascular and other serious diseases. It has developed a novel, allogeneic endothelial cell therapy for the repair and restorement of vascular function after injury by mimicking the body`s natural healing process. Pervasis is into exploration of broader indications for its groundbreaking technology in non-vascular applications like wound healing and inflammation, bone and joint repair. Recently, the company granted orphan drug designation for its Vascugel, which is in its clinical trail phase. Pervasis is headquartered in Massachusetts, the US.

Street: 
One Kendall Square
City: 
Cambridge
Federal State : 
United States
WebSite: 
www.pervasistx.com
Fax: 
1-617-6213408

Company Index Score

Current Index Score Historical Index Score
  • Pervasis Therapeutics, Inc. currently scores 50 % in the index.
  • Pervasis Therapeutics, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Pervasis Therapeutics, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets